This is an automatically translated article.
Venlift od 75 medicine has the main active ingredient Venlafaxine Hydrochloride 75mg and other excipients in sufficient quantity. Drugs are used in the treatment and prevention of depression effectively.
1. What is Venlift od 75?
Ingredients: The main active ingredient is Venlafaxine Hydrochloride 75mg and other excipients. The dosage form is a slow-release capsule. Packing: Box of 2 aluminum-aluminum blisters x 7 tablets. Effects of the drug Venlift od 75:
Active ingredient Venlafaxine and its active metabolite, namely O-desmethyl Venlafaxine (ODV), a potent inhibitor of neuronal reuptake of Serotonin and Norepinephrine and Weak inhibition of Dopamine reuptake. In addition, this substance also has anticholinergic, sedative and cardiovascular effects as seen with other psychotropic drugs. Active ingredient Venlafaxin and its metabolite ODV do not carry Monoamine Oxidase (MAO) inhibitory activity.
2. The effect of the drug Venlift od 75
Venlift od 75 is used in reducing anxiety, anti-depressants, preventing depression from recurring, treating anxiety disorders. Treatment of depression. Prevents recurrent episodes of depression and the onset of new episodes of depression. Treatment of anxiety or generalized anxiety disorder, long-term treatment.
3. Usage and dosage of Venlift od 75
3.1. Dosage of Venlift od 75 For people suffering from major depressive disorder or anxiety disorder:
Initial treatment dose is 75mg, once a day. After 2 weeks or more, if there is no response to treatment: gradually increase to 75mg/day, the interval between increments is not less than 4 days, to a maximum of 225mg/day. For people with social anxiety disorder:
Initial treatment dose is 75mg, 1 time / day. Treatment of panic disorder:
The starting dose is 37.5mg/day x 7 days, then 75mg/day. After about 2 weeks or longer, if there is no response to the dose of 75mg/day, gradually increase the level of 75mg/day, the intervals of increments are not less than 4 days, to the maximum therapeutic dose of 225mg/day. Treatment of severe depression or those who need a quick effect:
The recommended starting dose is 150mg/day in 3 divided doses. After that, the doctor may increase the daily dose by 50-75mg every 2-3 days until the desired therapeutic effect is achieved, the maximum dose is 375mg/day. Prophylaxis of recurrent and recurrent depression:
Your doctor may prescribe switching from immediate-release tablets to extended-release tablets: Equivalent daily therapeutic dose. For people with mild renal or hepatic impairment:
Reduce dose by 50%, for people with severe hepatic impairment, reduce the therapeutic dose even further. 3.2. How to take Venlift od-75 Venlift od 75mg is not affected by food. You can take the medicine on an empty stomach or on an empty stomach without affecting its effectiveness. You need to take Venlift od-75 with a full glass of water, do not crush or break the tablet.
4. In case of forgetting or overdose of medicine
When drug overdose: You may experience changes in the electrocardiogram, increased ventricular and synaptic rates, bradycardia, seizures. Rarely, an overdose of Venlift od-75 with other drugs and/or alcohol has resulted in death.
Treatment in case of overdose Venlift od-75 :
Ensure airway circulation, provide adequate oxygen and adequate ventilation. Carefully check your heart rate, pulse, temperature, blood pressure and breathing rate. A combination of supportive and symptomatic treatment is required. The doctor may prescribe activated charcoal, induce vomiting or perform gastric lavage. Do not use hemodialysis for both active ingredient Venlafaxine and O-desmethyl venlafaxine because the hemodialysis clearance of both substances is low.
5. Undesirable effects of the drug Venlift od 75
The most common undesirable effects associated with the use of Venlift od 75 are:
Nervous system disorders including dry mouth, dizziness, insomnia, nervousness or somnolence. Possible gastrointestinal disturbances include loss of appetite, constipation, nausea, vomiting, ejaculation/pleasure disorders, sweating, and weakness. The frequency of these undesirable effects is dose related. Adverse effects generally decrease in magnitude and frequency with prolonged use.
Inform the treating doctor about the unwanted effects you experience when using the drug.
6. Drug interactions Venlift od 75
Monoamine oxidase inhibitors (MAO): Concomitant use of Venlift od 75 is contraindicated in patients taking MAOIs. As with other drugs, there may be potential for interactions with a variety of mechanisms. Less than 35% of Venlafaxine and O-desmethyl Venlafaxine are bound to plasma proteins. Therefore, no drug interactions occur due to competition for plasma protein binding. The risk of co-administration with other CNS-acting agents has not been systematically evaluated (except for those mentioned below). Therefore, you need to be careful when using Venlift od 75 at the same time as these drugs. The pharmacokinetics of Venlafaxine and O-desmethyl venlafaxine were not altered when Venlafaxine was co-administered with Diazepam or Lithium to healthy volunteers. Active ingredient Venlafaxin did not affect the pharmacokinetics of Diazepam and Lithium in these studies. The use of Venlafaxine did not affect the psychoactive effects of Diazepam. Cimetidine inhibits the first-pass metabolism of Venlift od 75 but has no apparent effect on the formation or excretion of O-desmethyl venlafaxine, which is more abundant in the general circulation. In summary, the combined pharmacological effects of the active ingredients Venlafaxin and O-desmethyl venlafaxine will only be slightly increased. No dose adjustment is required when co-administering Venlift od 75 with cimetidine. However, for the elderly and people with liver failure who take both venlafaxine and cimetidine at the same time, it is not clear what the interaction will be. Therefore, the drug requires careful clinical monitoring for these patients. Symptoms obtained in clinical studies in subjects using Venlift od 75 concomitantly with antihypertensive or hypoglycemic agents have been evaluated for possible drug interactions. . There is no evidence to prove that there is an incompatibility between the use of the active ingredient Venlafaxin and other antihypertensive and hypoglycemic agents. There are no clinical studies evaluating the effectiveness of the combination of Venlift od 75 with other antidepressants.
7. Some notes when using Venlift od 75
Notes and cautions when using Venlift od 75:
Report to the treating doctor about your health situation, history, other drugs being treated. Use caution when using Venlift od 75 in people with a history of epilepsy, myocardial infarction, hemodynamic and metabolic disorders, unstable heart disease. Driving and operating machines Venlift od 75 may affect the user's ability to drive and use machines. If you want to use medication to treat depression, you must stop using Venlift od 75 for at least 7 days. Contraindications of Venlift od 75:
Do not use in combination or within 14 days after stopping using antidepressants. Venlift od 75 should be discontinued at least 7 days prior to treatment with an antidepressant. Persons with a history of hypersensitivity or hypersensitivity to any of the ingredients of the drug. People with high cardiovascular risk include ventricular arrhythmias, uncontrolled hypertension. Children under 18 years of age should not use the drug due to lack of clinical data. Note for use in pregnant women and nursing mothers:
Pregnant women: There are currently no specific reports, it is necessary to weigh the benefits and risks when using Venlift od 75 . Venlift od 75 should not be used during pregnancy unless the potential benefits outweigh the possible risks. Lactation: It is not known whether Venlift od 75 passes into breast milk. Therefore, Venlift od 75 should not be used by women who are breastfeeding. How to store the medicine:
Venlift od 75 should be stored in a cool, non-humid place with a temperature of 15 to 30 degrees Celsius. Do not store the medicine in the refrigerator freezer or places with high humidity. Do not expose Venlift od 75 to direct sunlight. It should be stored in an easy-to-remember, easy-to-reach place but out of reach of children and family pets. Above is some information about the uses of Venlift od 75, if you need advice or have any questions, please consult a qualified doctor/pharmacist for answers.
Please dial HOTLINE for more information or register for an appointment HERE. Download MyVinmec app to make appointments faster and to manage your bookings easily.
